Medpace Holdings, Inc. (MEDP)
620.10
-0.66
(-0.11%)
USD |
NASDAQ |
Aug 24, 16:00
620.10
0.00 (0.00%)
After-Hours: 20:00
Medpace Holdings Net Income (Quarterly) : 121.36M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 121.36M |
| March 31, 2026 | 123.87M |
| December 31, 2025 | 135.13M |
| September 30, 2025 | 111.14M |
| June 30, 2025 | 90.26M |
| March 31, 2025 | 114.60M |
| December 31, 2024 | 117.02M |
| September 30, 2024 | 96.43M |
| June 30, 2024 | 88.35M |
| March 31, 2024 | 102.55M |
| December 31, 2023 | 78.24M |
| September 30, 2023 | 70.50M |
| June 30, 2023 | 61.03M |
| March 31, 2023 | 72.84M |
| December 31, 2022 | 68.62M |
| September 30, 2022 | 65.98M |
| June 30, 2022 | 49.33M |
| March 31, 2022 | 61.28M |
| December 31, 2021 | 50.00M |
| September 30, 2021 | 48.42M |
| June 30, 2021 | 39.81M |
| March 31, 2021 | 43.17M |
| December 31, 2020 | 50.66M |
| Date | Value |
|---|---|
| September 30, 2020 | 41.32M |
| June 30, 2020 | 24.04M |
| March 31, 2020 | 28.88M |
| December 31, 2019 | 29.73M |
| September 30, 2019 | 23.91M |
| June 30, 2019 | 27.38M |
| March 31, 2019 | 19.14M |
| December 31, 2018 | 22.67M |
| September 30, 2018 | 19.23M |
| June 30, 2018 | 16.50M |
| March 31, 2018 | 14.49M |
| December 31, 2017 | 11.24M |
| September 30, 2017 | 9.815M |
| June 30, 2017 | 9.539M |
| March 31, 2017 | 8.435M |
| December 31, 2016 | -0.021M |
| September 30, 2016 | 5.036M |
| June 30, 2016 | 4.962M |
| March 31, 2016 | 3.448M |
| December 31, 2015 | -8.576M |
| September 30, 2015 | -0.133M |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| IQVIA Holdings, Inc. | 258.00M |
| Charles River Laboratories International, Inc. | -0.76M |
| Avantor, Inc. | 38.10M |
| Champions Oncology, Inc. | -0.667M |
| Personalis, Inc. | -31.68M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 707.33M |
| Total Expenses (Quarterly) | 585.97M |
| EPS Diluted (Quarterly) | 4.250 |
| Enterprise Value | 16.92B |
| Gross Profit Margin (Quarterly) | 27.56% |
| Profit Margin (Quarterly) | 17.16% |
| Earnings Yield | 2.75% |
| Operating Earnings Yield | 3.26% |
| Normalized Earnings Yield | 2.750 |